Autonomic Nervous System Drugs Practice Questions

Q: Which of the following drugs should be given in a patient with acute angle closure glaucoma, except?

Pilocarpine. **Explanation:** Acute Angle-Closure Glaucoma (AACG) is an ophthalmic emergency characterized by a rapid increase in intraocular pressure (IOP) due to the blockage of the drainage angle. The primary goal of treatment is to induce **miosis** (pupillary constriction) to pull the iris away from the trabecular meshwork, thereby opening the angle and facilitating aqueous humor outflow. **Why Pilocarpine is the Correct Answer:** **Pilocarpine** is a direct-acting cholinergic agonist (miotic). It acts on the $M_3$ receptors of the sphincter pupillae muscle, causing miosis. This physical movement of the iris clears the iridocorneal angle, making it the drug of choice for the emergency management of AACG. **Analysis of Incorrect Options (Drugs to be avoided):** The other options are drugs with **anticholinergic (atropine-like) properties**, which are strictly contraindicated in AACG: * **Clozapine:** An atypical antipsychotic with significant muscarinic antagonist activity. * **Fluphenazine:** A typical antipsychotic (phenothiazine) that possesses anticholinergic side effects. * **Paroxetine:** An SSRI that, unlike others in its class, has mild but clinically relevant anticholinergic effects. * **Mechanism of Danger:** Anticholinergic drugs cause **mydriasis** (pupillary dilation). In a predisposed eye, dilation causes the iris to bunch up at the periphery, further narrowing the angle and potentially precipitating a crisis of acute glaucoma. **High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice for AACG:** IV Acetazolamide (to reduce production) + Topical Pilocarpine (to increase drainage). * **Definitive Treatment:** Peripheral Iridotomy (Laser). * **Mydriatics to avoid in Glaucoma:** Atropine, Cyclopentolate, and Tricyclic Antidepressants (TCAs). * **Pilocarpine Side Effect:** Can cause "brow ache" due to ciliary muscle contraction (accommodative spasm).

Q: Which of the following can be blocked by atropine, a muscarinic receptor blocker?

Bradycardia caused by infusion of acetylcholine. **Explanation:** **1. Why Option C is Correct:** Atropine is a competitive antagonist of **muscarinic receptors (M1–M5)**. Acetylcholine (ACh) acts on M2 receptors located in the SA and AV nodes of the heart to cause a decrease in heart rate (bradycardia). Since atropine specifically blocks these muscarinic receptors, it prevents ACh from binding, thereby blocking the bradycardic effect. **2. Why Other Options are Incorrect:** * **Option A:** Nicotine increases blood pressure by stimulating **Nicotinic neuronal (Nn) receptors** in the autonomic ganglia and the adrenal medulla (releasing adrenaline). Atropine has no effect on nicotinic receptors; therefore, it cannot block nicotine-induced hypertension. * **Option B:** Neostigmine increases ACh levels at the neuromuscular junction. This ACh acts on **Nicotinic muscle (Nm) receptors** to increase skeletal muscle strength. Atropine does not block Nm receptors (which require neuromuscular blockers like d-tubocurarine). Thus, atropine does not reverse the skeletal muscle effects of cholinesterase inhibitors. * **Option D:** Since options A and B involve nicotinic receptors, this option is incorrect. **Clinical Pearls for NEET-PG:** * **Atropine Flush:** High doses of atropine cause cutaneous vasodilation (atropine flush), though the mechanism is not fully understood (likely non-cholinergic). * **Drug of Choice:** Atropine is the DOC for **symptomatic bradycardia** and **organophosphate poisoning** (to reverse muscarinic symptoms like salivation, lacrimation, and bronchoconstriction). * **Mnemonic for Atropine Toxicity:** "Hot as a hare, red as a beet, dry as a bone, blind as a bat, and mad as a hatter."

Q: Labetalol is an?

Alpha 1 and non-selective beta blocker. ### Explanation **Labetalol** is a unique antihypertensive agent that belongs to the class of **combined alpha and beta-adrenergic antagonists** [1], [4]. **1. Why Option D is Correct:** Labetalol acts as a competitive antagonist at **Alpha-1 ($\alpha_1$) receptors** and **Non-selective Beta receptors ($\beta_1$ and $\beta_2$)** [1]. * **Mechanism:** By blocking $\alpha_1$ receptors, it causes peripheral vasodilation and reduces peripheral vascular resistance [4]. Simultaneously, its $\beta$-blocking activity prevents the reflex tachycardia that usually follows vasodilation [1]. * **Potency Ratio:** The $\beta:\alpha$ blockade ratio is approximately **3:1** for oral administration and **7:1** for intravenous administration. **2. Why Other Options are Incorrect:** * **Option A & B:** Labetalol is not a pure alpha-blocker. While it blocks $\alpha_1$, it has no significant effect on $\alpha_2$ receptors (unlike Phentolamine) [3]. * **Option C:** Labetalol is **non-selective** for beta receptors. It blocks both $\beta_1$ (heart) and $\beta_2$ (bronchioles/blood vessels). A drug that is $\alpha_1$ and selective $\beta_1$ blocker is **Carvedilol** (though Carvedilol is also technically non-selective, it is often compared similarly; however, Labetalol is the classic textbook example for this specific question profile) [1]. **3. High-Yield Clinical Pearls for NEET-PG:** * **Drug of Choice (DOC):** Labetalol is the first-line agent for **Hypertension in Pregnancy** (Preeclampsia/Eclampsia) because it is safe for the fetus. * **Hypertensive Emergencies:** It is used IV for rapid blood pressure control (e.g., aortic dissection, pheochromocytoma) [2]. * **Side Effects:** Postural hypotension (due to $\alpha_1$ block) and bronchospasm (due to $\beta_2$ block). * **Intrinsic Sympathomimetic Activity (ISA):** Labetalol possesses mild $\beta_2$-agonist activity (partial agonist), which further aids vasodilation.

Q: Which of the following drugs is used in this test?

Tolazoline. ***Tolazoline*** - **Tolazoline** is an **alpha-adrenergic blocker** used as a pharmacological adjunct in **Meckel's diverticulum scintigraphy** to inhibit the release of **Tc-99m pertechnetate** from ectopic gastric mucosa. - By blocking gastric acid secretion, it enhances **visualization** of the Meckel's diverticulum by allowing greater accumulation of the radiotracer in the ectopic gastric tissue. *Clonidine* - **Clonidine** is an **alpha-2 agonist** used primarily for **hypertension** and **ADHD**, not for nuclear medicine imaging studies. - It has no role in **Meckel's diverticulum scintigraphy** and would not enhance visualization of ectopic gastric mucosa. *Bismuth* - **Bismuth** compounds are used for **H. pylori eradication** and as **antidiarrheal agents**, not in nuclear imaging procedures. - It would interfere with **Tc-99m pertechnetate** uptake rather than enhance visualization in Meckel's scan. *Oxymetazoline* - **Oxymetazoline** is an **alpha-1 agonist** used as a **nasal decongestant** with vasoconstrictor properties. - It has no application in **nuclear medicine** and would not be beneficial for enhancing Meckel's diverticulum visualization.

Q: Fasciculations are caused by which of the following agents?

Suxamethonium. **Explanation:** The correct answer is **Suxamethonium (Succinylcholine)**. **1. Why Suxamethonium is correct:** Suxamethonium is the only **depolarizing neuromuscular blocker** used clinically. It acts as an agonist at the nicotinic acetylcholine receptors (nAChR) at the neuromuscular junction. Unlike acetylcholine, it is not metabolized by acetylcholinesterase, leading to prolonged depolarization of the post-synaptic membrane. This initial stimulation causes disorganized muscle fiber contractions known as **fasciculations** before the muscle eventually becomes flaccid (Phase I block). **2. Why the other options are incorrect:** * **Pancuronium, d-Tubocurarine, and Vecuronium** are all **non-depolarizing neuromuscular blockers**. They act as competitive antagonists at the nAChR. By simply blocking the receptor without activating it, they prevent depolarization from occurring. Consequently, they do not cause fasciculations; they result in immediate muscle relaxation. **3. Clinical Pearls & High-Yield Facts for NEET-PG:** * **Pre-curarization:** To prevent post-operative myalgia caused by fasciculations, a small "defasciculating dose" of a non-depolarizing agent (e.g., Vecuronium) is sometimes given before Suxamethonium. * **Metabolism:** Suxamethonium is metabolized by **Pseudocholinesterase** (Plasma cholinesterase). Deficiency of this enzyme leads to prolonged apnea. * **Side Effects:** Hyperkalemia (critical in burn/trauma patients), increased intraocular/intragastric pressure, and it is a potent trigger for **Malignant Hyperthermia**. * **Drug of Choice:** Due to its rapid onset (30–60s) and short duration (5–10 mins), it is the drug of choice for **Rapid Sequence Induction (RSI)**.

Q: Which glaucoma drug is a beta-1 selective beta-blocker?

Betaxolol. Betaxolol is a **cardioselective (Beta-1 selective)** adrenergic antagonist [2]. In the management of glaucoma, it works by blocking $\beta_1$ receptors on the ciliary epithelium, thereby reducing the production of aqueous humor and lowering intraocular pressure (IOP) [1]. Because it is $\beta_1$ selective, it carries a lower risk of inducing bronchospasm compared to non-selective agents, making it the preferred beta-blocker for patients with co-existing respiratory conditions like asthma or COPD (though it should still be used with caution) [1]. **2. Analysis of Incorrect Options:** * **Timolol (A):** The "Gold Standard" for glaucoma treatment, but it is a **non-selective** beta-blocker ($\beta_1 + \beta_2$). It is contraindicated in patients with asthma/COPD due to the risk of life-threatening bronchospasm from $\beta_2$ blockade. * **Levobunolol (B):** A potent **non-selective** beta-blocker similar to Timolol, often used for its long duration of action. * **Carteolol (C):** A **non-selective** beta-blocker that possesses **Intrinsic Sympathomimetic Activity (ISA)**. It is unique because it may cause less bradycardia and has a "membrane-stabilizing" effect, but it is not $\beta_1$ selective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic:** Remember **"B"** for **B**etaxolol is **B**eta-1 selective. * **Efficacy:** While safer for the lungs, Betaxolol is slightly **less effective** at lowering IOP compared to Timolol. * **Side Effects:** Local side effects of topical beta-blockers include stinging, burning, and dry eyes. Systemic absorption can lead to bradycardia and heart block. * **Contraindications:** All topical beta-blockers are generally contraindicated in patients with 2nd or 3rd-degree heart block or severe bradycardia.

Q: What is the recommended treatment for atropine toxicity?

Physostigmine. **Explanation:** **Correct Answer: D. Physostigmine** **Mechanism of Action:** Atropine toxicity is characterized by competitive antagonism of muscarinic receptors (causing symptoms like "mad as a hatter, dry as a bone, red as a beet"). **Physostigmine** is the drug of choice because it is a **tertiary amine** acetylcholinesterase inhibitor. Unlike other carbamates (like Neostigmine), Physostigmine is lipid-soluble and **crosses the blood-brain barrier (BBB)**. This allows it to reverse both the peripheral and the life-threatening central anticholinergic effects (delirium, seizures, coma) of atropine. **Analysis of Incorrect Options:** * **A. 2-Pralidoxime (2-PAM):** This is a cholinesterase reactivator used specifically for **Organophosphate poisoning**. It would worsen atropine toxicity as atropine is actually used as an antidote for OP poisoning. * **B. Naloxone:** A competitive opioid antagonist used to reverse **Opioid overdose** (respiratory depression/miosis). * **C. Flumazenil:** A competitive GABA-A receptor antagonist used to reverse **Benzodiazepine overdose**. **High-Yield Clinical Pearls for NEET-PG:** * **Mnemonic for Atropine Toxicity:** "Hot as a hare (hyperthermia), Red as a beet (flushing), Dry as a bone (anhidrosis), Blind as a bat (mydriasis/cycloplegia), Mad as a hatter (delirium)." * **Why not Neostigmine?** Neostigmine is a quaternary ammonium compound; it does not cross the BBB and therefore cannot treat the central CNS symptoms of atropine toxicity. * **Contraindication:** Physostigmine should be avoided in Tricyclic Antidepressant (TCA) overdose as it may aggravate cardiac conduction defects.

Question 1

Which of the following properties makes pyridostigmine different from neostigmine?

Accepted Answer

It is longer acting

Answer

It is more potent

Answer

It produces fewer muscarinic side effects

Answer

It has no direct action on neuromuscular receptors

Question 2

Which of the following drugs should be given in a patient with acute angle closure glaucoma, except?

Accepted Answer

Pilocarpine

Answer

Clozapine

Answer

Fluphenazine

Answer

Paroxetine

Question 3

Which of the following can be blocked by atropine, a muscarinic receptor blocker?

Accepted Answer

Bradycardia caused by infusion of acetylcholine

Answer

Increased blood pressure caused by nicotine

Answer

Increased skeletal muscle strength caused by neostigmine, an acetylcholinesterase inhibitor

Answer

All of these

Question 4

Labetalol is an?

Accepted Answer

Alpha 1 and non-selective beta blocker

Answer

Alpha 1 blocker

Answer

Alpha 2 blocker

Answer

Alpha 1 and selective beta 1 blocker

Question 5

Which of the following drugs is used in this test?

Accepted Answer

Tolazoline

Answer

Clonidine

Answer

Bismuth

Answer

Oxymetazoline

Question 6

What is the most important action of beta-blockers in glaucoma?

Accepted Answer

Decrease in the production of aqueous humor

Answer

Membrane stabilizing effect

Answer

Retinal neuron protecting effect

Answer

Pupillary constriction

Question 7

Fasciculations are caused by which of the following agents?

Accepted Answer

Suxamethonium

Answer

Pancuronium

Answer

d-Tubocurarine

Answer

Vecuronium

Question 8

In the beginning of resuscitation efforts, 0.5 mg of epinephrine is administered subcutaneously. Which adrenergic receptors, in which tissues, are responsible for the beneficial effect of epinephrine in this patient?

Accepted Answer

Alpha-1 receptors in vascular smooth muscle, beta-1 receptors in the heart, and beta-2 receptors in bronchial smooth muscle

Answer

Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors in the heart, and beta-1 receptors in bronchial smooth muscle

Answer

Alpha-1 receptors in vascular smooth muscle, alpha-2 receptors at presynaptic nerve terminals, beta-1 receptors in bronchial smooth muscle

Answer

Alpha-2 receptors in vascular smooth muscle and beta-2 receptors in vascular smooth muscle

Question 9

Which glaucoma drug is a beta-1 selective beta-blocker?

Accepted Answer

Betaxolol

Answer

Timolol

Answer

Levobunolol

Answer

Carteolol

Question 10

What is the recommended treatment for atropine toxicity?

Accepted Answer

Physostigmine

Answer

2-Pralidoxime

Answer

Naloxone

Answer

Flumazenil

Autonomic Nervous System Drugs — MCQs

Autonomic Nervous System Drugs — MCQs

On this page

Practice by Chapter

Want unlimited practice?